Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
1
×
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
What
approval
bid
1
×
boehringer
diabetes
1
×
drug
1
×
eli
expand
fallen
fda
ingelheim
lilly
marketed
medicine’s
patients
rejects
short
type
Language
unset
Current search:
bid
×
fda
×
drug
×
diabetes
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes